TTK HEALTHCARE LIMITED (TTKHLTCARE) financials

TTK HEALTHCARE LIMITED (TTKHLTCARE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

TTK Healthcare Ltd is a standalone TTK Group company in consumer /OTC brands, animal health, medical devices, condoms/sexual-wellness and ready-to-fry foods. HumanPharma was divested in May 2022;agreements to sell EVA and GoodHome were signed in July 2026.[1][2]

Market Cap: ₹1,417Cr.
Current Price: ₹1,003
Stock P/E: 18.5
ROE: 6.30%
ROCE: 8.04%
Book Value: ₹789
Dividend Yield: 1.00%
52W High / Low: ₹1,250/735

In Jun 2026, TTK HEALTHCARE LIMITED (TTKHLTCARE) reported sales ₹258 Cr and net profit ₹21 Cr.

Annual TTM: sales ₹888 Cr, net profit ₹74 Cr.

Shareholding: Promoters 74.57% (Sep 2026), FIIs 1.95% (Sep 2026), DIIs 0.11% (Sep 2026), Public 23.37% (Sep 2026), No. of Shareholders 23,993% (Sep 2026).

TTKHLTCARE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	198	205	190	226	204	209	218	258
Expenses	190	197	178	224	198	202	207	243
Operating Profit	8	8	12	3	5	7	11	15
OPM %	4.2%	3.8%	6%	1.2%	2.6%	3.4%	5%	6%
Other Income	18	18	13	18	19	10	21	17
Interest	1	1	1	1	1	1	1	1
Depreciation	2	2	2	2	2	2	2	2
Profit before tax	23	23	22	18	21	14	30	29
Tax %	26%	26%	26%	26%	4%	25%	26%	26%
Net Profit	17	17	16	13	20	11	22	21
EPS in Rs	12.17	11.84	11.43	9.20	14.43	7.45	15.40	15.06
Raw PDF	—	—	—	—	—	—	—	—

TTKHLTCARE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	646	476	599	725	753	801	857	888
Expenses	617	457	577	694	715	767	831	850
Operating Profit	28	19	22	31	37	35	26	38
OPM %	4.4%	4.1%	3.6%	4.3%	5.0%	4.3%	3.0%	4.3%
Other Income	9	28	42	643	63	85	68	67
Interest	3	2	3	5	3	3	3	3
Depreciation	14	13	13	13	13	8	9	9
Profit before tax	19	32	48	657	84	108	83	94
Tax %	37%	-44%	13%	3%	25%	25%	20%	—
Net Profit	12	46	42	640	63	82	66	74
EPS in Rs	8.72	32.87	29.43	452.72	44.47	57.79	46.48	52.34
Dividend Payout %	34%	18%	34%	2%	22%	17%	22%	—

TTKHLTCARE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	14	14	14	14	14	14	14	14
Reserves	237	235	281	316	939	987	1,051	1,101
Borrowings	29	30	19	22	27	23	24	24
Other Liabilities	136	152	180	207	189	183	192	190
Total Liabilities	416	431	494	559	1,170	1,206	1,281	1,329
Fixed Assets	98	89	85	80	71	75	81	73
CWIP	2	9	0	0	3	1	0	1
Investments	13	9	13	15	13	13	11	9
Other Assets	304	325	395	463	1,083	1,118	1,189	1,246
Total Assets	416	431	494	559	1,170	1,206	1,281	1,329

TTKHLTCARE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	17	20	96	45	-25	-5	-4	-21
Cash from Investing Activity	10	-13	-77	-30	32	28	20	52
Cash from Financing Activity	-31	-10	-17	-10	-12	-22	-18	-18
Net Cash Flow	-4	-4	2	5	-6	2	-2	13
Free Cash Flow	13	8	95	42	-36	-15	6	-25
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	62%	108%	391%	248%	-28%	54%	68%	-31%

TTKHLTCARE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	74.57%	74.57%	74.57%	74.57%	74.57%	74.57%	74.57%	74.57%
FIIs	1.90%	1.90%	1.89%	1.90%	1.89%	1.90%	1.86%	1.95%
DIIs	1.14%	1.14%	1.18%	1.18%	1.08%	1.11%	2.19%	0.11%
Public	22.39%	22.40%	22.37%	22.37%	22.46%	22.43%	21.39%	23.37%
No. of Shareholders	15,780	15,899	16,112	16,134	22,481	23,686	22,809	23,993

TTKHLTCARE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	47	43	46	33	46	42	41	47
Inventory Days	77	101	123	102	89	105	107	98
Days Payable	101	121	170	134	116	110	106	83
Cash Conversion Cycle	22	23	-2	1	19	36	43	63
Working Capital Days	-6	-3	-32	-28	4	49	48	161
ROCE %	15%	8%	6%	8%	10%	9%	9%	8%

TTKHLTCAREUpdated 21 Oct 2026, 2:51

Ttk Healthcare Limited

TTKHLTCAREUpdated 21 Oct 2026, 2:51

Market Cap

₹1,417Cr.

Current Price

₹1,003

High / Low

₹1,250/735

Stock P/E

18.5

ROE6.30%

ROCE8.04%

Book Value₹789

Face Value₹10.0

Dividend Yield1.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	202	1	192	15	3	21	24	16	11.09
Sep 2023	186	1	176	16	3	22	26	16	11.33
Dec 2023	184	0	179	16	3	18	27	13	9.12
Mar 2024	181	1	169	16	3	24	25	18	12.93
Jun 2024	208	1	201	37	2	41	23	32	22.35
Sep 2024	198	1	190	18	2	23	26	17	12.17
Dec 2024	205	1	197	18	2	23	26	17	11.84
Mar 2025	190	1	178	13	2	22	26	16	11.43
Jun 2025	226	1	224	18	2	18	26	13	9.2
Sep 2025	204	1	198	19	2	21	4	20	14.43
Dec 2025	209	1	202	10	2	14	25	11	7.45
Mar 2026	218	1	207	21	2	30	26	22	15.4
Jun 2026	258	1	243	17	2	29	26	21	15.06

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	483	4	453	7	6	26	39	16	20.81
Mar 2016	519	3	478	6	7	36	36	23	29.19
Mar 2017	528	3	489	6	12	29	36	19	24.13
Mar 2018	578	5	535	8	15	30	40	18	12.86
Mar 2019	628	3	578	8	15	39	38	24	17.25
Mar 2020	646	3	617	9	14	19	37	12	8.72
Mar 2021	476	2	457	28	13	32	-44	46	32.87
Mar 2022	599	3	577	42	13	48	13	42	29.43
Mar 2023	725	5	694	643	13	657	3	640	452.72
Mar 2024	753	3	715	63	13	84	25	63	44.47
Mar 2025	801	3	767	85	8	108	25	82	57.79
Mar 2026	857	3	831	68	9	83	20	66	46.48
TTM	888	3	850	67	9	94	—	74	52.34

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	74.57%
FIIs	1.95%
DIIs	0.11%
Public	23.37%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	74.57%	1.85%	3.13%	20.46%
Mar 2024	74.57%	1.85%	1.14%	22.45%
Jun 2024	74.57%	1.87%	1.14%	22.44%
Sep 2024	74.57%	1.9%	1.14%	22.39%
Dec 2024	74.57%	1.9%	1.14%	22.39%
Mar 2025	74.57%	1.9%	1.14%	22.4%
Jun 2025	74.57%	1.89%	1.18%	22.37%
Sep 2025	74.57%	1.9%	1.18%	22.37%
Dec 2025	74.57%	1.89%	1.08%	22.46%
Mar 2026	74.57%	1.9%	1.11%	22.43%
Jun 2026	74.57%	1.86%	2.19%	21.39%
Sep 2026	74.57%	1.95%	0.11%	23.37%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	8	110	42	115	275	52	46	0	177	275
Mar 2016	8	128	38	128	303	106	1	10	185	303
Mar 2017	8	150	23	104	285	99	0	9	177	285
Mar 2018	14	219	47	127	407	110	1	9	288	407
Mar 2019	14	237	29	136	416	98	2	13	304	416
Mar 2020	14	235	30	152	431	89	9	9	325	431
Mar 2021	14	281	19	180	494	85	0	13	395	494
Mar 2022	14	316	22	207	559	80	0	15	463	559
Mar 2023	14	939	27	189	1170	71	3	13	1083	1170
Mar 2024	14	987	23	183	1206	75	1	13	1118	1206
Mar 2025	14	1051	24	192	1281	81	0	11	1189	1281
Mar 2026	14	1101	24	190	1329	73	1	9	1246	1329

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	39	-49	3	-7
Mar 2016	37	-27	-11	0
Mar 2017	18	5	-23	0
Mar 2018	25	-22	-7	-4
Mar 2019	17	10	-31	-4
Mar 2020	20	-13	-10	-4
Mar 2021	96	-77	-17	2
Mar 2022	45	-30	-10	5
Mar 2023	-25	32	-12	-6
Mar 2024	-5	28	-22	2
Mar 2025	-4	20	-18	-2
Mar 2026	-21	52	-18	13

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	34	33	24	35	47	43	46	33	46	42	41	47
Inventory Days	62	66	65	80	77	101	123	102	89	105	107	98
Days Payable	50	53	100	130	101	121	170	134	116	110	106	83
Cash Conversion Cycle	46	46	-11	-16	22	23	-2	1	19	36	43	63
Working Capital Days	-31	-38	-24	-30	-6	-3	-32	-28	4	49	48	161
ROCE %	20%	23%	18%	15%	15%	8%	6%	8%	10%	9%	9%	8%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of TTK HEALTHCARE LIMITED (TTKHLTCARE)?

The reported market capitalisation for TTK HEALTHCARE LIMITED (TTKHLTCARE) is ₹1,417Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of TTKHLTCARE?

The current price shown for TTK HEALTHCARE LIMITED (TTKHLTCARE) on Fincrux is ₹1,003 with a 52-week high/low of ₹1,250/735.

What is the P/E ratio of TTK HEALTHCARE LIMITED (TTKHLTCARE)?

The stock P/E for TTK HEALTHCARE LIMITED (TTKHLTCARE) is 18.5 on Fincrux, with ROE at 6.30% and ROCE at 8.04%.

What were TTKHLTCARE latest quarterly results?

For Jun 2026, TTK HEALTHCARE LIMITED (TTKHLTCARE) reported sales ₹258 Cr and net profit ₹21 Cr (figures in ₹ crore unless noted).

What are TTKHLTCARE annual sales and net profit?

For TTM, TTK HEALTHCARE LIMITED (TTKHLTCARE) shows sales of ₹888 Cr and net profit of ₹74 Cr on the Fincrux profit & loss statement.

Who owns TTK HEALTHCARE LIMITED (TTKHLTCARE)?

Latest shareholding for TTK HEALTHCARE LIMITED (TTKHLTCARE) on Fincrux: Promoters 74.57% (Sep 2026), FIIs 1.95% (Sep 2026), DIIs 0.11% (Sep 2026), Public 23.37% (Sep 2026), No. of Shareholders 23,993% (Sep 2026).

Where can I find TTK HEALTHCARE LIMITED (TTKHLTCARE) financials?

TTK HEALTHCARE LIMITED (TTKHLTCARE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show TTKHLTCARE balance sheet and cash flow?

Yes. The TTK HEALTHCARE LIMITED (TTKHLTCARE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 21 October 2026 at 2:51